Skip to content
Toggle navigation
ABOUT US
MANAGEMENT TEAM
BOARD OF DIRECTORS
DyrctAxess
PRESTALIADIRECT
PRODUCTS
PRESTALIA
PARTNERING
INVESTOR RELATIONS
PRESS RELEASES
EVENTS & PRESENTATIONS
ANNUAL MEETINGS
SEC FILINGS
INVESTOR RESOURCES
CORPORATE GOVERNANCE
FAQs
CONTACT
5/03/2016
Marina Biotech to Acquire Late-Stage Program from Turing Pharmaceuticals
Post navigation
←
5/17/2016
5/03/2016
→
Scroll Up